MedTrace Logo

High Protein Breakfast on Postprandial Glycemia in T2D (PBD)

NCT02854202 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-08-03

No results posted yet for this study

Summary

The investigators hypothesis is that eating whey protein in breakfast will reduce overall postprandial glycemia in individuals with type 2 diabetes (T2D).

Conditions

Interventions

OTHER

Arm1: Whey protein

Arm1: Whey protein:The participants will consume 42 g protein, namely from Whey protein in the breakfast

OTHER

Arm 2 Breakfast- other proteins

Arm 2 Breakfast- other proteins: The participants will be assigned to 42 g protein of other protein sources at breakfast

OTHER

Arm 3 Breakfast- low protein

Arm 3: Low protein' :The participants will consume 22 g protein at breakfast

Sponsors & Collaborators

  • Tel Aviv University

    collaborator OTHER

  • Hospital de Clinicas Caracas

    lead OTHER

Principal Investigators

  • Daniela Jakubowicz, MD · Wolfson Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-12-31
Completion
2016-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02854202 on ClinicalTrials.gov